Pharma Mar, S.A.

DB:PMRA Stock Report

Market Cap: €1.3b

Pharma Mar Management

Management criteria checks 2/4

Pharma Mar's CEO is Jose Fernandez Sousa-Faro, appointed in Jan 1986, has a tenure of 40.67 years. directly owns 6.44% of the company’s shares, worth €82.57M. The average tenure of the management team and the board of directors is 15.5 years and 5 years respectively.

Key information

Jose Fernandez Sousa-Faro

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure40.7yrs
CEO ownership6.4%
Management average tenure15.5yrs
Board average tenure5yrs

Recent management updates

Recent updates

CEO

Jose Fernandez Sousa-Faro

40.7yrs
Tenure
€294,000
Compensation

Mr. José María Fernández Sousa-Faro, Ph D., founded Pharma Mar, S.A.U. in 1986. He Founded Noscira, S.A., in 2000.He serves as the Chief Executive Officer and President of Pharma Mar, S.A.U. He serves as...

Leadership Team

NamePositionTenureCompensationOwnership
Jose Fernandez Sousa-Faro
Founder40.7yrs€294.00k6.44%
€ 82.6m
Pedro Fernandez Puentes
Executive Vice-Chairmanno data€124.00k0.00058%
€ 7.4k
Juan Carretero
Founderno datano datano data
María de Francia Caballero
Chief Financial Officer26.7yrsno datano data
José Moreno Martinez-Losa
Head of Capital Markets & Investor Relations11.7yrsno datano data
Juan Pulido
General Counsel & Secretary of the Board of Directors7yrsno datano data
Sandra Sanchez
Global Compliance Head6.3yrsno datano data
Lara Vadillo
Communication Directorno datano datano data
Belén Veramendi
Director of Corporate Development4.7yrsno datano data
Luis Cuenca
Director of Human Resources & IT23.2yrsno datano data
Luis Mora Capitan
Managing Director of Oncology & Virology Business Units19.4yrsno datano data
Pascal Besman
Senior Vice President of Strategic Developmentno datano datano data
15.5yrs
Average Tenure

Experienced Management: PMRA's management team is seasoned and experienced (15.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jose Fernandez Sousa-Faro
Founderno data€294.00k6.44%
€ 82.6m
Pedro Fernandez Puentes
Executive Vice-Chairmanno data€124.00k0.00058%
€ 7.4k
Eduardo Serra Rexach
Independent Other External Director5.7yrs€35.00k0.062%
€ 798.7k
M. Solchaga Catalan
Independent Other External Directorno data€35.00kno data
Montserrat Andrade Detrell
Proprietary Directorno data€34.00k5.53%
€ 70.9m
Blanca Hernandez Rodriguez
Independent Director7.7yrsno data0.010%
€ 133.1k
Maria Sandra Mera
Representative Proprietary Director5.8yrsno datano data
Emiliano Aller
Independent Director4.3yrsno datano data
Fernando Santos
Independent Other External Directorno datano data0.010%
€ 133.1k
Soledad Miranda
Lead Independent Director3.3yrsno datano data
Juan Manuel Vieites de Sousa
Independent Directorless than a yearno datano data
5.0yrs
Average Tenure

Experienced Board: PMRA's board of directors are considered experienced (5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 15:53
End of Day Share Price 2026/09/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharma Mar, S.A. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jaime EscribanoBanco Santander
Patricia CifuentesBestinver Sociedad De Valores, S.A
Kambiz YazdiBTIG